And, to make a great week even better, I've been included as an author on a paper for the first time! 🎉 So proud of all the work my amazingly talented colleagues did to make this happen and I was very proud to lend my bioinformatics experience to it 🧠
https://t.co/26xfr0KolA
How can we better understand the impact of genetics on Alzheimer's risk?
We spoke to @HazelLRoberts about her role in IPMAR, a major UK DRI initiative that established 100 stem cell lines, capturing the effects of Alzheimer's risk genes👉https://t.co/BOS50hF1ur
How can we better understand the impact of genetics on Alzheimer's risk?
We spoke to @HazelLRoberts about her role in IPMAR, a major UK DRI initiative that established 100 stem cell lines, capturing the effects of Alzheimer's risk genes👉https://t.co/BOS50hF1ur
My first ever research paper is out !! 👩🏼🔬🎉
👉👉https://t.co/GoDwQC3MwO
A natural product "brazilin" inhibits the NLRP3 inflammasome pathway, a key driver of numerous inflammatory human diseases including those affecting the brain such as stroke and dementia.
Great to see coverage on @BBC news re treatment for @Alzheimers. Watch @BBCPanorama for the full story where I speak w/@BBCFergusWalsh on new Alzheimer's meds. Benefits are modest but show potential for a new generation of effective therapies. 1/2
https://t.co/3jqAu2a6I0
Is the NHS ready for new Alzheimer's treatments? A BBC Panorama programme airs at 8pm tonight.
The UK DRI's Prof John Hardy was on @BBCr4today this morning discussing lecanemab and donanemab.
Listen from 01:35:53⬇️
https://t.co/LHpEOUBANA
It was amazing to have such an inspiring talk from @azziejo yesterday about her and her family's journey with Alzheimer's disease. Definitely reminds us why all those hours in the lab are so important!
Exciting Postdoc position in my lab at Cardiff
@UKDRI and collaborating with Prof Steve Finkbeiner. Please consider applying if you are interested in studying the molecular mechanisms of Alzheimer's using super cool imaging! Please spread the word 📢🧠🔬
https://t.co/tJ45L6p4tT
What role could the immune system play in #Parkinsons? T cells, a type of white blood cell, may have a part to play in the disease. @CynthiaSandor4 (UK DRI at Cardiff) will investigate in her recently awarded Future Leaders Fellowship from @UKRI_News👏👉https://t.co/E4XvZJHtkT
Great ARUK Leadership Training today! ✨️ @EmmaCFalkner's expertise illuminated paths of self-discovery and leadership! Thanks to Emma and Beccy @AlzResearchUK Wales network for organising! 🍊
Congratulations to Race Against Dementia Fellow, Dr Wioleta Zelek who is one of @UKDRI x @lifearc1's funding recipients for her work in developing an antibody therapy targeting complement, part of the innate immune system for Alzheimer’s -> https://t.co/1SUQ2pMYPw
The Blood Biomarker Challenge will revolutionise how we diagnose dementia in the UK in the future, shifting the dial on what is possible in terms of offering accurate, quick, timely diagnosis for people living with dementia.💙#ResearchisHope
At Imperial today for the @UKDRI Molecular Epidemiology and Big Data in Dementia Research workshop! Kicking off with a plenary about the role of epidemiologists and the impact of Alzheimer's epidemiology by Professor Albert Hofman of @HarvardEpi#UKDRI